IndiaInfoline » Markets » GLAXO

Glaxosmithkline Pharmaceuticals Ltd - Share Price

GLAXO

Open

1,553.00

Prev. Close

1,551.05

Turnover (lac.)

235

Day's High

1,560.00

Day's Low

1,548.70

52 Week's High

1,807.50

52 Week's Low

962.65

Book Value

120

Face Value

10

Mkt Cap (Cr.)

26,258

P/E

71.24

EPS

21.76

Divi. Yield

2.58

Glaxosmithkline Pharmaceuticals LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Glaxosmithkline Pharmaceuticals LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd547.6045.38130,763.76724.810.733,207.24106.10
Divis Laboratories Ltd3,684.3554.9696,627.91513.300.441,713.78313.47
Dr Reddys Laboratories Ltd4,887.0032.8480,637.51481.000.523,333.60979.45
Cipla Ltd761.6027.2661,140.71745.640.533,711.03233.61
Aurobindo Pharma Ltd894.2019.5852,092.87801.540.344,425.43246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Glaxosmithkline Pharmaceuticals LtdSummary & Reports

GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc, UK, one of the worlds leading research-based pharmaceutical and healthcare companies. The companys product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, card... More

Registered Office

GSK House,Dr Annie Besant Road Worli,Mumbai, Maharashtra,400030

Tell. : +91-022-24959595
Website : http://www.gsk-india.com
Email : askus@gsk.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

View

- <

Reco. Price

Oct 29,2020 02:17 PM

Target Price

Target Returns:

0.00%

Result Express

Glaxosmithkline Pharma Ltd's Q1FY19 standalone net profit rises 602.98% yoy to Rs96.87cr : Beats Estimates

Dec 03, 2020 01:25 PM

The company’s standalone revenue stood at Rs735.65cr, up 21.1% yoy but down 1.73% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    28 Oct 2020

    Annc. Date

    28 Sep 2020

    GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of t... More

  • Purpose

    Board Meeting

    Exp. Date

    29 Jul 2020

    Annc. Date

    01 Jul 2020

    GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of t... More